MedTrace Logo

Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre

NCT04446338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-06-24

No results posted yet for this study

Summary

A sequential combination of different antibodies test against SARS-CoV-2 is evaluated. The protocol included a rapid test and several ELISA tests within a defined cohort of healthcare workers.

Conditions

  • History of Covid-19, Seroprevalence

Interventions

DIAGNOSTIC_TEST

Antibody Test

Presence and Titer of Anti-Sars-CoV-2 Antbodies

Sponsors & Collaborators

  • Institute of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine

    collaborator UNKNOWN

  • University Hospital Tuebingen

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-13
Primary Completion
2020-06-30
Completion
2020-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446338 on ClinicalTrials.gov